Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149492147> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2149492147 endingPage "125" @default.
- W2149492147 startingPage "114" @default.
- W2149492147 abstract "Purpose – The purpose of this paper is to identify risk factors for interruptions in opioid dependence treatment and barriers to (re) entering effective treatment through real-world insight on current opioid dependence treatment in the UK. Design/methodology/approach – Project Access UK, a national survey deployed across multiple regions in England, Wales and Scotland, collected data on the perspectives of patients receiving medication-assisted treatment (MAT) for opioid dependence ( n =248), out-of-treatment opioid users ( n =196), and physicians ( n =100). Findings – Both patients and users reported multiple prior episodes of MAT and detoxification. Among patients, 57 per cent reported continuing illicit drugs use in addition to their treatment, 25 per cent had misused (injected or snorted) and 30 per cent had diverted (sold or given away) prescribed opioid medications. Diverted medications were currently being used by 26 per cent of out-of-treatment users; of these, 21 per cent used methadone. Supervised dosing was rated as the condition of treatment with the biggest impact on daily life. Daily supervision was a requirement for 44, 34 and 23 per cent of patients receiving methadone, mono-buprenorphine and buprenorphine-naloxone, respectively. Practical implications – Interruptions to opioid dependence treatment in various forms can hamper the recovery of opioid-dependent patients. The benefits of MAT may not be fully realised if treatment is interrupted due to compliance failure, or inflexible treatment programmes leading to premature treatment exit. These findings serve to highlight areas in which treatment disruption can potentially be addressed. Originality/value – Consideration of these findings may aid in the optimisation of treatment delivery practices to better meet the UK policy of recovery, and ultimately improve patient outcomes." @default.
- W2149492147 created "2016-06-24" @default.
- W2149492147 creator A5042401820 @default.
- W2149492147 creator A5065130922 @default.
- W2149492147 date "2014-08-26" @default.
- W2149492147 modified "2023-09-24" @default.
- W2149492147 title "Interruption of medication-assisted treatment for opioid dependence: insights from the UK" @default.
- W2149492147 cites W1659527729 @default.
- W2149492147 cites W1973562905 @default.
- W2149492147 cites W1974518105 @default.
- W2149492147 cites W1986048137 @default.
- W2149492147 cites W2008795452 @default.
- W2149492147 cites W2031176986 @default.
- W2149492147 cites W2071956502 @default.
- W2149492147 cites W2073606903 @default.
- W2149492147 cites W2092853006 @default.
- W2149492147 cites W2106280777 @default.
- W2149492147 cites W2113698968 @default.
- W2149492147 cites W2118605713 @default.
- W2149492147 cites W2119421920 @default.
- W2149492147 cites W2124486489 @default.
- W2149492147 cites W2167195669 @default.
- W2149492147 doi "https://doi.org/10.1108/dat-01-2014-0002" @default.
- W2149492147 hasPublicationYear "2014" @default.
- W2149492147 type Work @default.
- W2149492147 sameAs 2149492147 @default.
- W2149492147 citedByCount "1" @default.
- W2149492147 countsByYear W21494921472023 @default.
- W2149492147 crossrefType "journal-article" @default.
- W2149492147 hasAuthorship W2149492147A5042401820 @default.
- W2149492147 hasAuthorship W2149492147A5065130922 @default.
- W2149492147 hasConcept C118552586 @default.
- W2149492147 hasConcept C126322002 @default.
- W2149492147 hasConcept C170493617 @default.
- W2149492147 hasConcept C177713679 @default.
- W2149492147 hasConcept C194828623 @default.
- W2149492147 hasConcept C2777288759 @default.
- W2149492147 hasConcept C2778750930 @default.
- W2149492147 hasConcept C2778767360 @default.
- W2149492147 hasConcept C2778949969 @default.
- W2149492147 hasConcept C2781063702 @default.
- W2149492147 hasConcept C2986900798 @default.
- W2149492147 hasConcept C48856860 @default.
- W2149492147 hasConcept C71924100 @default.
- W2149492147 hasConceptScore W2149492147C118552586 @default.
- W2149492147 hasConceptScore W2149492147C126322002 @default.
- W2149492147 hasConceptScore W2149492147C170493617 @default.
- W2149492147 hasConceptScore W2149492147C177713679 @default.
- W2149492147 hasConceptScore W2149492147C194828623 @default.
- W2149492147 hasConceptScore W2149492147C2777288759 @default.
- W2149492147 hasConceptScore W2149492147C2778750930 @default.
- W2149492147 hasConceptScore W2149492147C2778767360 @default.
- W2149492147 hasConceptScore W2149492147C2778949969 @default.
- W2149492147 hasConceptScore W2149492147C2781063702 @default.
- W2149492147 hasConceptScore W2149492147C2986900798 @default.
- W2149492147 hasConceptScore W2149492147C48856860 @default.
- W2149492147 hasConceptScore W2149492147C71924100 @default.
- W2149492147 hasIssue "3" @default.
- W2149492147 hasLocation W21494921471 @default.
- W2149492147 hasOpenAccess W2149492147 @default.
- W2149492147 hasPrimaryLocation W21494921471 @default.
- W2149492147 hasRelatedWork W17608643 @default.
- W2149492147 hasRelatedWork W2005481147 @default.
- W2149492147 hasRelatedWork W2091295574 @default.
- W2149492147 hasRelatedWork W2100166028 @default.
- W2149492147 hasRelatedWork W2142613079 @default.
- W2149492147 hasRelatedWork W2184218697 @default.
- W2149492147 hasRelatedWork W2402416928 @default.
- W2149492147 hasRelatedWork W2461248502 @default.
- W2149492147 hasRelatedWork W3015431761 @default.
- W2149492147 hasRelatedWork W3136679719 @default.
- W2149492147 hasVolume "14" @default.
- W2149492147 isParatext "false" @default.
- W2149492147 isRetracted "false" @default.
- W2149492147 magId "2149492147" @default.
- W2149492147 workType "article" @default.